Synribo Interactions
There are 578 drugs known to interact with Synribo (omacetaxine), along with 3 disease interactions. Of the total drug interactions, 134 are major, and444 are moderate.
- View all 578 medications that may interact with Synribo
- View Synribo disease interactions (3)
Most frequently checked interactions
View interaction reports for Synribo (omacetaxine) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- amlodipine
- ampicillin / sulbactam
- Arava (leflunomide)
- Arcapta (indacaterol)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- axicabtagene ciloleucel
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- belantamab mafodotin
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- chloramphenicol ophthalmic
- clonidine
- Copaxone (glatiramer)
- Corlanor (ivabradine)
Synribo disease interactions
There are 3 disease interactions with Synribo (omacetaxine) which include:
More about Synribo (omacetaxine)
- Synribo consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.